©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 14, 2015; 21(14): 4121-4125
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4121
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4121
Optimum chemotherapy for the management of advanced biliary tract cancer
Marwan Ghosn, Hampig Raphael Kourie, Elie El Rassy, Ralph Chebib, Fadi El Karak, Colette Hanna, Dolly Nasr, Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut 2038 3054, Lebanon
Author contributions: Ghosn M initiated the review; Ghosn M, Kourie HR, El Rassy E performed the review, analyzed the data and wrote first draft; Ghosn M, Kourie HR, El Rassy E, Chebib R, El Karak F, Hanna C and Nasr D reviewed and commented on the paper and provided final approval.
Conflict-of-interest: To the best of our knowledge, no conflict of interest exists.
Correspondence to: Marwan Ghosn, MD, Department of Oncology, Faculty of Medicine, Saint Joseph University, Monot St, Beirut, PO Box 166830, Beirut 2038 3054, Lebanon. mghosn.hdf@usj.edu.lb
Telephone: +961-1-3226842 Fax: +961-1-1613397
Received: November 30, 2014
Peer-review started: November 30, 2014
First decision: December 26, 2014
Revised: January 13, 2015
Accepted: February 13, 2015
Article in press: February 13, 2015
Published online: April 14, 2015
Processing time: 136 Days and 8.8 Hours
Peer-review started: November 30, 2014
First decision: December 26, 2014
Revised: January 13, 2015
Accepted: February 13, 2015
Article in press: February 13, 2015
Published online: April 14, 2015
Processing time: 136 Days and 8.8 Hours
Core Tip
Core tip: This paper is a recent study outlining the most recent updates on the treatment of advanced biliary tract cancers. After a brief review of the different treatments used for advanced biliary tract cancers, current treatment options, novel therapies and future approaches are discussed.